SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001159036-20-000018
Filing Date
2020-03-20
Accepted
2020-03-20 16:06:21
Documents
9
Period of Report
2019-12-31
Effectiveness Date
2020-03-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A PROXY halodefproxy2020.htm DEF 14A 879365
2 a2019bonusplana01.jpg GRAPHIC 42740
3 ceopaya01.jpg GRAPHIC 36668
4 halologobwa09.jpg GRAPHIC 38428
5 htsignaturea10.jpg GRAPHIC 31598
6 otherneospaya01.jpg GRAPHIC 39964
7 slide1b05.jpg GRAPHIC 52580
8 svpsignaturea01.jpg GRAPHIC 23400
9 svpsignaturea02.jpg GRAPHIC 23400
  Complete submission text file 0001159036-20-000018.txt   1236267
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32335 | Film No.: 20732039
SIC: 2836 Biological Products, (No Diagnostic Substances)